Insider · CIK 0002089048
Neilesh Shailesh Ghodadra
Files at TTRX (Turn Therapeutics Inc.). First filing -, latest -.
In brief
Neilesh Shailesh Ghodadra files SEC Form 4 as officer and director at TTRX (Turn Therapeutics Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Neilesh Shailesh Ghodadra has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 1 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Oct 8, 2025 | TTRX Turn Therapeutics Inc. | AGrant or award Common Stock | +10,000 | $0.00 | $0 | 10,000 | Oct 10, 2025 |
Questions about Neilesh Shailesh Ghodadra
Answered from the filings on this page, as of the latest one.
Is Neilesh Shailesh Ghodadra buying or selling?
Neilesh Shailesh Ghodadra has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Neilesh Shailesh Ghodadra's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Neilesh Shailesh Ghodadra has 0.
Where does Neilesh Shailesh Ghodadra file Form 4?
Neilesh Shailesh Ghodadra has filed Form 4 at TTRX (Turn Therapeutics Inc.) as Chief Medical Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.